Medication use and polypharmacy in patients referred to a tertiary gastroenterology practice

被引:4
作者
Chris-Olaiya, Abimbola [1 ]
Palmer, William [2 ]
Stancampiano, Fernando [3 ]
Lacy, Brian [2 ]
Heckman, Michael [4 ]
Chirila, Razvan [3 ]
Nikpour, Naveed [5 ]
Mcleod, Ethan [5 ]
Ryan, Taylor [5 ]
Maillis, Alex [5 ]
Vargas, Emily [4 ]
Bouras, Ernest [2 ]
机构
[1] Univ Kentucky, Dept Hepatol, Lexington, KY 40506 USA
[2] Mayo Clin Florida, Div Gastroenterol, Jacksonville, FL USA
[3] Mayo Clin Florida, Dept Med, Jacksonville, FL USA
[4] Mayo Clin Florida, Div Biomed Stat & Informat, Jacksonville, FL USA
[5] Mayo Clin Florida, Clin Res Internship Study Program, Jacksonville, FL USA
关键词
adverse effects; gastrointestinal; polypharmacy; prescription medicine; UNITED-STATES; GUIDELINES;
D O I
10.2478/rjim-2020-0016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction. Commonly prescribed medications are associated with various gastrointestinal (GI) side effects but few data are available on prescription medication use and polypharmacy in a gastroenterology outpatient practice. We aimed to examine the prevalence of polypharmacy, defined as the simultaneous use of 5 or more medications. Methods. A descriptive correlational study of consecutive outpatient consultations in 988 patients referred to a tertiary gastroenterology practice. Main outcome measurements were frequency of prescription medication use and polypharmacy. Results. The most common GI symptoms were abdominal pain (72%), nausea (57%), and constipation (53%). The frequency of polypharmacy was 10%. Eighty percent of patients took at least one medication and 60% took two or more. The most frequently used medication classes were proton pump inhibitors (43%), followed by benzodiazepines (30%), selective serotonin-reuptake or norepinephrine-reuptake inhibitors (28%), non-steroidal anti-inflammatory drugs (27%), and opioids (21%). Conclusion. There was a higher use of prescription medicine including antidepressants, and a lower frequency of polypharmacy in our study cohort compared to the general population. The use of medications may have contributed to the symptoms leading to our study's population GI consultation.
引用
收藏
页码:228 / 232
页数:5
相关论文
共 18 条
  • [1] Polypharmacy in older patients: identifying the need for support by a community pharmacist
    Beuscart, Jean-Baptiste
    Petit, Segolene
    Gautier, Sophie
    Wierre, Patrick
    Balcaen, Thibaut
    Lefebvre, Jean-Marc
    Kambia, Nicolas
    Bertoux, Elisabeth
    Mascaut, Daniel
    Barthelemy, Christine
    Cuny, Damien
    Puisieux, Francois
    Decaudin, Bertrand
    [J]. BMC GERIATRICS, 2019, 19 (01)
  • [2] Polypharmacy Patterns: Unravelling Systematic Associations between Prescribed Medications
    Calderon-Larranaga, Amaia
    Gimeno-Feliu, Luis A.
    Gonzalez-Rubio, Francisca
    Poblador-Plou, Beatriz
    Lairla-San Jose, Maria
    Abad-Diez, Jose M.
    Poncel-Falco, Antonio
    Prados-Torres, Alexandra
    [J]. PLOS ONE, 2013, 8 (12):
  • [3] Opioids in Gastroenterology: Treating Adverse Effects and Creating Therapeutic Benefits
    Camilleri, Michael
    Lembo, Anthony
    Katzka, David A.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (09) : 1338 - 1349
  • [4] Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health
    Chial, HJ
    Camilleri, M
    Burton, D
    Thomforde, G
    Olden, KW
    Stephens, D
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2003, 284 (01): : G130 - G137
  • [5] Burden of Digestive Diseases in the United States Part I: Overall and Upper Gastrointestinal Diseases
    Everhart, James E.
    Ruhl, Constance E.
    [J]. GASTROENTEROLOGY, 2009, 136 (02) : 376 - 386
  • [6] Determinants of polypharmacy and compliance with GOLD guidelines in patients with chronic obstructive pulmonary disease
    Franssen, Frits M. E.
    Spruit, Martijn A.
    Wouters, Emiel F. M.
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2011, 6 : 493 - 501
  • [7] Adverse drug events in ambulatory care
    Gandhi, TK
    Weingart, SN
    Borus, J
    Seger, AC
    Peterson, J
    Burdick, E
    Seger, DL
    Shu, K
    Federico, F
    Leape, LL
    Bates, DW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (16) : 1556 - 1564
  • [8] Clinical response to tricyclic antidepressants in functional bowel disorders is not related to dosage
    Halpert, A
    Dalton, CB
    Diamant, NE
    Toner, BB
    Hu, YM
    Morris, CB
    Bangdiwala, SI
    Whitehead, WE
    Drossman, DA
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (03) : 664 - 671
  • [9] Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia
    Hoffmann, Falk
    van den Bussche, Hendrik
    Wiese, Birgitt
    Schoen, Gerhard
    Koller, Daniela
    Eisele, Marion
    Glaeske, Gerd
    Scherer, Martin
    Kaduszkiewicz, Hanna
    [J]. BMC PSYCHIATRY, 2011, 11
  • [10] Central & peripheral nervous systems - Treatment of opioid-induced gut dysfunction
    Holzer, Peter
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (02) : 181 - 194